Reduction of dietary sodium to less than 100 mmol in heart failure (SODIUM-HF): an international, open-label, randomised, controlled trial von Ezekowitz, Justin A, Colin-Ramirez, Eloisa, Ross, Heather, Escobedo, Jorge, Macdonald, Peter, Troughton, Richard, Saldarriaga, Clara, Alemayehu, Wendimagegn, McAlister, Finlay A, Arcand, JoAnne, Atherton, John, Doughty, Robert, Gupta, Milan, Howlett, Jonathan, Jaffer, Shahin, Lavoie, Andrea, Lund, Mayanna, Marwick, Thomas, McKelvie, Robert, Moe, Gordon, Pandey, A Shekhar, Porepa, Liane, Rajda, Miroslaw, Rheault, Haunnah, Singh, Jitendra, Toma, Mustafa, Virani, Sean, Zieroth, Shelley, Ezekowitz, Justin, Colin-Ramirez, Eloisa, Ross, Heather, Escobedo, Jorge, Macdonald, Peter, Troughton, Richard, Saldarriaga, Clara, Alemayehu, Wendimagegn, McAlister, Finlay, Arcand, JoAnne, Atherton, John, Doughty, Robert, Gupta, Milan, Howlett, Jonathan, Jaffer, Shahin, Lavoie, Andrea, Lund, Mayanna, Marwick, Thomas, McKelvie, Robert, Moe, Gordon, Pandey, A. Shekhar, Porepa, Liane, Rajda, Miroslaw, Rheault, Haunnah, Singh, Jitendra, Toma, Mustafa, Virani, Sean, Zieroth, Shelley

Volltext

Hypofractionated versus conventionally fractionated radiotherapy for patients with localised prostate cancer (HYPRO): final efficacy results from a randomised, multicentre, open-la... von Incrocci, Luca, Prof, Wortel, Ruud C, MD, Alemayehu, Wendimagegn Ghidey, PhD, Aluwini, Shafak, MD, Schimmel, Erik, MD, Krol, Stijn, MD, van der Toorn, Peter-Paul, MD, Jager, Hanja de, MD, Heemsbergen, Wilma, PhD, Heijmen, Ben, Prof, Pos, Floris, MD

Volltext

Hypofractionated versus conventionally fractionated radiotherapy for patients with prostate cancer (HYPRO): late toxicity results from a randomised, non-inferiority, phase 3 trial von Aluwini, Shafak, Dr, Pos, Floris, PhD, Schimmel, Erik, MD, Krol, Stijn, PhD, van der Toorn, Peter Paul, MD, de Jager, Hanja, MD, Alemayehu, Wendimagegn Ghidey, PhD, Heemsbergen, Wilma, PhD, Heijmen, Ben, Prof, Incrocci, Luca, Prof

Volltext

N-Terminal Pro-B-Type Natriuretic Peptide and Clinical Outcomes: Vericiguat Heart Failure With Reduced Ejection Fraction Study von Ezekowitz, Justin A, O'Connor, Christopher M, Troughton, Richard W, Alemayehu, Wendimagegn G, Westerhout, Cynthia M, Voors, Adriaan A, Butler, Javed, Lam, Carolyn S P, Ponikowski, Piotr, Emdin, Michele, Patel, Mahesh J, Pieske, Burkert, Roessig, Lothar, Hernandez, Adrian F, Armstrong, Paul W

Volltext

Hypofractionated versus conventionally fractionated radiotherapy for patients with prostate cancer (HYPRO): acute toxicity results from a randomised non-inferiority phase 3 trial von Aluwini, Shafak, Dr, Pos, Floris, MD, Schimmel, Erik, MD, van Lin, Emile, MD, Krol, Stijn, MD, van der Toorn, Peter Paul, MD, de Jager, Hanja, MD, Dirkx, Maarten, PhD, Alemayehu, Wendimagegn Ghidey, PhD, Heijmen, Ben, Prof, Incrocci, Luca, MD

Volltext

Efficacy and safety of vericiguat in patients with heart failure with reduced ejection fraction treated with sacubitril/valsartan: insights from the VICTORIA trial von Senni, Michele, Alemayehu, Wendimagegn G., Sim, David, Edelmann, Frank, Butler, Javed, Ezekowitz, Justin, Hernandez, Adrian F., Lam, Carolyn S.P., O'Connor, Christopher M., Pieske, Burkert, Ponikowski, Piotr, Roessig, Lothar, Voors, Adriaan A., Westerhout, Cynthia M., McMullan, Ciaran, Armstrong, Paul W.

Volltext

Assessment of Biomarkers of Myocardial injury, Inflammation, and Renal Function in Heart Failure With Reduced Ejection Fraction: The VICTORIA Biomarker Substudy von DEFILIPPI, CHRISTOPHER R., ALEMAYEHU, WENDIMAGEGN G., VOORS, ADRIAAN A., KAYE, DAVID, BLAUSTEIN, ROBERT O., BUTLER, JAVED, EZEKOWITZ, JUSTIN A., HERNANDEZ, ADRIAN F., LAM, CAROLYN S.P., ROESSIG, LOTHAR, SELIGER, STEPHEN, SHAH, PALAK, WESTERHOUT, CYNTHIA M., ARMSTRONG, PAUL W., O'CONNOR, CHRISTOPHER M.

Volltext

High-throughput targeted proteomics discovery approach and spontaneous reperfusion in ST-segment elevation myocardial infarction von Shavadia, Jay S., Granger, Christopher B., Alemayehu, Wendimagegn, Westerhout, Cynthia M., Povsic, Thomas J., Brener, Sorin J., van Diepen, Sean, Defilippi, Christopher, Armstrong, Paul W.

Volltext

N-Terminal Pro-B-Type Natriuretic Peptide and Clinical Outcomes von Ezekowitz, Justin A., O’Connor, Christopher M., Troughton, Richard W., Alemayehu, Wendimagegn G., Westerhout, Cynthia M., Voors, Adriaan A., Butler, Javed, Lam, Carolyn S.P., Ponikowski, Piotr, Emdin, Michele, Patel, Mahesh J., Pieske, Burkert, Roessig, Lothar, Hernandez, Adrian F., Armstrong, Paul W.

Volltext

Long-Term Clinical Outcomes Following Revascularization in High-Risk Coronary Anatomy Patients With Stable Ischemic Heart Disease von Bainey, Kevin R, Alemayehu, Wendimagegn, Welsh, Robert C, Kumar, Arnav, King, 3rd, Spencer B, Kirtane, Ajay J

Volltext

Frontline low-dose alemtuzumab with fludarabine and cyclophosphamide prolongs progression-free survival in high-risk CLL von Geisler, Christian H., van t' Veer, Mars B., Jurlander, Jesper, Walewski, Jan, Tjønnfjord, Geir, Itälä Remes, Maija, Kimby, Eva, Kozak, Tomas, Polliack, Aaron, Wu, Ka Lung, Wittebol, Shulamiet, Abrahamse-Testroote, Martine C.J., Doorduijn, Jeanette, Ghidey Alemayehu, Wendimagegn, van Oers, Marinus H.J.

Volltext

Toxicity and quality of life after high-dose-rate brachytherapy as monotherapy for low- and intermediate-risk prostate cancer von Aluwini, Shafak, Busser, Wendy M.H, Ghidey Alemayehu, Wendimagegn, Boormans, Joost L, Kirkels, Wim J, Jansen, Peter P, Praag, John O, Bangma, Chris H, Kolkman-Deurloo, Inger-Karine K

Volltext

Novel Biomarkers, ST-Elevation Resolution, and Clinical Outcomes Following Primary Percutaneous Coronary Intervention von Shavadia, Jay S, Granger, Christopher B, Alemayehu, Wendimagegn, Westerhout, Cynthia M, Povsic, Thomas J, Van Diepen, Sean, Defilippi, Christopher, Armstrong, Paul W

Volltext

Clonal diversity predicts adverse outcome in chronic lymphocytic leukemia von Leeksma, Alexander C., Taylor, Justin, Wu, Bian, Gardner, Jeffrey R., He, Jie, Nahas, Michelle, Gonen, Mithat, Alemayehu, Wendimagegn G., te Raa, Doreen, Walther, Tatjana, Hüllein, Jennifer, Dietrich, Sascha, Claus, Rainer, de Boer, Fransien, de Heer, Koen, Dubois, Julie, Dampmann, Maria, Dürig, Jan, van Oers, Marinus H. J., Geisler, Christian H., Eldering, Eric, Levine, Ross L., Miller, Vincent, Mughal, Tariq, Lamanna, Nicole, Frattini, Mark G., Heaney, Mark L., Zelenetz, Andrew, Zenz, Thorsten, Abdel-Wahab, Omar, Kater, Arnon P.

Volltext

Circulating troponin and further left ventricular ejection fraction improvement in patients with previously recovered left ventricular ejection fraction von Howlett, Jonathan G., Sharma, Nakul, Alemayehu, Wendimagegn G., Dyck, Jason R.B., Anderson, Todd, Fine, Nowell, Becker, Harald, White, James A., Paterson, D. Ian, Thompson, Richard B., Oudit, Gavin Y., Haykowsky, Mark J., Ezekowitz, Justin A.

Volltext

Temporal changes in biomarkers and their relationships to reperfusion and to clinical outcomes among patients with ST segment elevation myocardial infarction von van Diepen, Sean, Alemayehu, Wendimagegn G., Zheng, Yinggan, Theroux, Pierre, Newby, L. Kristin, Mahaffey, Kenneth W., Granger, Christopher B., Armstrong, Paul W.

Volltext

High vs. low oxygen therapy in patients with acute heart failure: HiLo‐HF pilot trial von Sepehrvand, Nariman, Alemayehu, Wendimagegn, Rowe, Brian H., McAlister, Finlay A., Diepen, Sean, Stickland, Michael, Ezekowitz, Justin A.

Volltext

Genome-wide association study (GWAS)-identified disease risk alleles do not compromise human longevity von Beekman, Marian, Nederstigt, Christa, Suchiman, H. Eka D., Kremer, Dennis, van der Breggen, Ruud, Lakenberg, Nico, Alemayehu, Wendimagegn Ghidey, de Craen, Anton J. M., Westendorp, Rudi G. J., Boomsma, Dorret I., de Geus, Eco J. C., Houwing-Duistermaat, Jeanine J., Heijmans, Bastiaan T., Slagboom, P. Eline, Cantor, Charles R.

Volltext

The influence of comorbidities on achieving an N‐terminal pro‐b‐type natriuretic peptide target: a secondary analysis of the GUIDE‐IT trial von Ezekowitz, Justin A., Alemayehu, Wendimagegn, Rathwell, Sarah, Grant, Andrew D., Fiuzat, Mona, Whellan, David J., Ahmad, Tariq, Adams, Kirkwood, Piña, Ileana L., Cooper, Lawton S., Januzzi, James L., Leifer, Eric S., Mark, Daniel, O'Connor, Christopher M., Felker, G. Michael

Volltext

Soluble CD52 is an indicator of disease activity in chronic lymphocytic leukemia von Vojdeman, FJ, Herman, SEM, Kirkby, N, Wiestner, A, van t' Veer, MB, Tjonnfjord, GE, Itala-Remesg, MA, Kimby, E, Farooqui, MZ, Polliack, A, Wu, KL, Doorduijn, JK, Alemayehu, WG, Wittebol, S, Kozak, T, Walewski, J, Abrahamse-Testroote, MCJ, Van Oers, MHJ, Geisler, CH, Niemann, CU

Volltext